Outlook Therapeutics (OTLK) Q3 2025 Earnings

14AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.89
-0.71
-0.53
-0.35

Details

Expected EPS
-0.3525
Actual EPS
-0.44
Surprise EPS
-0.09
Surprise Percent
+24.82%

Description

Outlook Therapeutics (OTLK) has reported earnings of -0.44 per share for Q3 2025.

0 Comments

Share your thoughts